Skip to main content
. 2022 Nov 23;24(2):e54006. doi: 10.15252/embr.202154006

Figure 3. Lysosomal mtDNA‐dependent TLR9 promotes CSC expansion.

Figure 3

  • A
    CSCs were stimulated with CpG ODN (10 μg/ml) or control and analyzed for sphere formation and tumorgenicity. Mean ± SEM from six experiments.
  • B, C
    CSCs transfected with mtDNA were analyzed for sphere formation and tumorgenicity. Mean ± SEM from six experiments.
  • D
    CSCs were transfected with two different TLR9 shRNAs or the control, and analyzed for sphere formation and tumorgenicity. Mean ± SEM from six experiments.
  • E, F
    CSCs transfected with DNase II expression vector, DNase II shRNA, or the control was analyzed for sphere formation. Mean ± SEM from six patients.
  • G
    CpG promoted tumor growth of PDX chimeras. Mean ± SEM from six mice.
  • H
    TLR9 inhibitor chloroquine abrogated the effect of CpG on tumor growth in PDX chimeras. Mean ± SEM from six mice.
  • I
    CpG treatment increased the frequency of CD133‐expressing CSCs in PDX chimeras. Mean ± SEM from six mice.
  • J
    Chloroquine impeded the function of CpG in elevating CD133‐expressing CSCs of PDX chimeras. Mean ± SEM from six mice.

Data information: Paired t‐test with Bonferroni method, **P < 0.01, ***P < 0.001.

Source data are available online for this figure.